BU
TECH icon

BBVA USA’s Bio-Techne TECH Stock Holding History

BBVA USA’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$12K Hold
96
– – ﹤0.01% 814
2021
Q2 		$11K Buy
+96
New +$10.1K ﹤0.01% 852

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

BBVA USA's TECH Position: Q3 2021 in Review

BBVA USA held its Bio-Techne (TECH) position steady in Q3 2021 at 96 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #814.

BBVA USA first reported a position in TECH in Q2 2021 and has held it in 2 quarters since. 566 funds tracked by Wall St. Rank hold TECH as of Q3 2021.

  • BBVA USA held 96 shares of Bio-Techne worth $12K as of Q3 2021.
  • BBVA USA left its Bio-Techne share count unchanged in Q3 2021.
  • Bio-Techne made up ﹤0.01% of BBVA USA's portfolio in Q3 2021, its #814 holding.
  • BBVA USA first reported a position in Bio-Techne in Q2 2021 and has held it in 2 quarters since.
  • 566 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.